Products

Microscopy with LED technology: The EUROStar series

Do you  remember 2005? It was the year of USB flash drives, Bluetooth headsets, digital cameras – and the EUROStar. The first EUROIMMUN microscope was designed to simplify microscopy and eliminate the long waiting times required to fully warm up the mercury vapour lamps used in conventional microscopes. Thanks to its LED light source, the […]

Products

Let’s change the perspective together! — ChLIA for allergy diagnostics

Keep the overview and focus on relevance and quality with our carefully selected portfolio in allergy diagnostics. In allergy diagnostics, chemiluminescence immunoassays (ChLIA) contribute to quick and precise identification of sensitisations to allergens. They allow specific determination of IgE antibodies in the blood, which can cause allergic reactions. This is especially important when traditional skin

Science

Novel cell-based assay for autoantibody detection in demyelination

A novel cell-based immunofluorescence assay (CBA) provides sensitive and specific detection of IgM antibodies against myelin-associated glycoprotein (MAG), as demonstrated in a study published in collaboration with scientists from the University of Verona and the Pediatric Research Institute in Padua, Italy. The Anti-MAG CBA is now available for research use*. Anti-MAG-IgM antibodies are markers for

Products, Science

Neurological symptoms: a diagnostic challenge

There is a huge variety of neurological diseases and it often takes specialists a long time to figure out the cause of a patient’s symptoms. Doctors regularly encounter patients with unspecific neurological complaints. In these cases, differential diagnostics is crucial to finding the right therapy. Even if the doctor has a suspicion and there are

Science

Novel autoantibody against DAGLA discovered in cerebellitis

Diacylglycerol lipase alpha (DAGLA) has been identified as a novel autoantibody target in patients with rapid progressive cerebellar ataxia. The autoantibodies were characterised as part of a collaborative study between scientists at EUROIMMUN (Lübeck, Germany), the Hannover Medical School, (Hannover, Germany) and further institutes and clinics. The study was published in April 2024 the journal

Scroll to Top